Lukas Gerstweiler

Jan 23, 2025 | bioprocessonline.com | Lukas Gerstweiler |Zhen Zhang

Guest Column | January 23, 2025 By Lukas Gerstweiler and Zhen Zhang, University of Adelaide Artificial intelligence (AI) and machine learning (ML) have revolutionized industries from finance to pharmaceuticals, with high-profile successes such as DeepMind’s AlphaFold, which dramatically advanced protein structure prediction. Yet, the bioprocessing sector has been slower to adopt AI for process development, control, and analysis.